to identify, implement and validate innovative community centered approaches to cancer clinical trials education.
Only
3 to 5 percent of all adult cancer patients participate in clinical trials.
Minorities
with cancer are less likely to be offered participation in a clinical trial.
There
are many barriers that limit access to clinical trials at the local community
level.
“There
must be enhanced efforts at minority patient
recruitment and retention to (cancer) clinical
trials...success
will require sustained, aggressive action and new partnerships between
policymakers, healthcare professionals, professional
societies and underserved communities.”